Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Massimo, Valerio"'
Autor:
Blaz Pavlovic, Konstantin Bräutigam, Florence Dartiguenave, Paul Martel, Arnas Rakauskas, Valérie Cesson, Markus Veit, Pascal Oechslin, Alexander Gu, Thomas Hermanns, Karim Saba, Cédric Poyet, Andreas M. Hötker, Niels J. Rupp, Massimo Valerio, Laurent Derré, Daniel Eberli, Irina Banzola
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Prostate-Specific Antigen (PSA) based screening of prostate cancer (PCa) needs refinement. The aim of this study was the identification of urinary biomarkers to predict the Prostate Imaging—Reporting and Data System (PI-RADS) score and the
Externí odkaz:
https://doaj.org/article/b6949f6ccd9044508a54959dcc3ab281
Autor:
Jonathan Maurer, Philippe J. Eugster, Kiana Collins, Céline Vocat, Jason Oke, Brian Nicholson, Arnas Rakauskas, Eric Grouzmann, Massimo Valerio
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 12-15 (2024)
Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related pe
Externí odkaz:
https://doaj.org/article/d6ea4678d9af4f75bc222ae90b9bcd4b
Autor:
Christoph Würnschimmel, Dominik Menges, Maciej Kwiatkowski, Silvan Sigg, Lukas Prause, Agostino Mattei, Daniel Engeler, Daniel Eberli, Helge Seifert, Massimo Valerio, Cyrill A. Rentsch, Ashkan Mortezavi
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 5 (2024)
Over a decade ago, the United States Preventive Services Taskforce (USPSTF) recommended against prostate-specific antigen (PSA)-based screening for prostate cancer in all men, which considerably influenced prostate cancer screening policies worldwide
Externí odkaz:
https://doaj.org/article/5f843392790c4c25b94d4ba6b70e8bf2
Autor:
Giancarlo Marra, Giorgio Calleris, Emilia Massari, Elena Vissio, Luca Molinaro, Paola Cassoni, Daniele D'Agate, Marco Oderda, Massimo Valerio, Yannick Raskin, Steven Joniau, Mauro Papotti, Paolo Gontero
Publikováno v:
European Urology Open Science, Vol 47, Iss , Pp 110-118 (2023)
Background: Most prostate cancer (PCa) recurrences after nonsurgical first-line treatment are managed with androgen deprivation therapy (ADT). When local treatment is indicated, salvage focal treatment (FT) may achieve outcomes similar to those after
Externí odkaz:
https://doaj.org/article/96cf4cb16450451b80d2c8335ee13e9c
Autor:
Arnas Rakauskas, Max Peters, Paul Martel, Peter S. N. van Rossum, Stefano La Rosa, Jean-Yves Meuwly, Beat Roth, Massimo Valerio
Publikováno v:
PLoS ONE, Vol 18, Iss 1 (2023)
Introduction High-resolution micro-ultrasound (micro-US) is a novel precise imaging modality that allows targeted prostate biopsies and multiparametric magnet resonance imaging (mpMRI) fusion. Its high resolution relying on a 29 MHz transducer allows
Externí odkaz:
https://doaj.org/article/00440cd0aa1041738bf59ed6983b439c
Autor:
Arnas Rakauskas, Thomas Tawadros, Ilaria Lucca, Fernanda Herrera, Jean Bourhis, Rodolfo Burruni, Maria Natal Gomes, Caroline Codeluppi, Laura Jolliet, Stefano La Rosa, Jean-Yves Meuwly, Patrice Jichlinski, Dominik Berthold, Massimo Valerio
Publikováno v:
Investigative and Clinical Urology, Vol 62, Iss 4, Pp 416-422 (2021)
Purpose: To compare the clinical outcome of males with low-risk and favorable intermediate-risk prostate cancer managed within a standardized modern protocol of active surveillance. Materials and Methods: This was a prospective cohort study with str
Externí odkaz:
https://doaj.org/article/4fdeec1637a24fc58f556caec1048763
Autor:
Giancarlo Marra, Taimur T. Shah, Daniele D’Agate, Alessandro Marquis, Giorgio Calleris, Luca Lunelli, Claudia Filippini, Marco Oderda, Marco Gatti, Massimo Valerio, Rafael Sanchez-Salas, Alberto Bossi, Juan Gomez-Rivas, Francesca Conte, Desiree Deandreis, Olivier Cussenot, Umberto Ricardi, Paolo Gontero
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
IntroductionCurrently, the majority of prostate cancer (PCa) recurrences after non-surgical first-line treatment are managed with androgen-deprivation therapy (ADT). Salvage radical prostatectomy (sRP) is a curative alternative to ADT but yields sign
Externí odkaz:
https://doaj.org/article/d9df163f722c46348b85415aec2098e7
Autor:
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, Igor Tsaur, Francesco Ceci, Massimo Valerio, Derya Tilki, Giancarlo Marra, Felix Preisser, Christian D. Fankhauser, Fabio Zattoni, Peter Chiu, Ignacio Puche-Sanz, Jonathan Olivier, Roderik C. N. van den Bergh, Veeru Kasivisvanathan, Andreas Pircher, Irene Virgolini, Giorgio Gandaglia
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Radioligand therapy with Lutetium-177 (177Lu)-Prostate-specific membrane antigen (PSMA) has shown to prolong survival in metastatic castration resistant prostate cancer (mCRPC). One of the major challenges for clinicians in the future is to select th
Externí odkaz:
https://doaj.org/article/232c37a650224a71b52e995656347cde
Autor:
Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, Alexander Kretschmer, Giancarlo Marra, Alessandro Magli, Felix Preisser, Derya Tilki, Igor Tsaur, Massimo Valerio, Roderick van den Bergh, Claudia Kesch, Francesco Ceci, Christian Fankhauser, Giorgio Gandaglia
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
The role and timing of radiotherapy (RT) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) remains controversial. While recent trials support the oncological safety of early salvage RT (SRT) compared to adjuvant RT (ART) in se
Externí odkaz:
https://doaj.org/article/a9d8d32c6c764a94a920f5110617bc17
Autor:
Arnas Rakauskas, Giancarlo Marra, Isabel Heidegger, Veeru Kasivisvanathan, Alexander Kretschmer, Fabio Zattoni, Felix Preisser, Derya Tilki, Igor Tsaur, Roderick van den Bergh, Claudia Kesch, Francesco Ceci, Christian Fankhauser, Giorgio Gandaglia, Massimo Valerio
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Focal therapy is a modern alternative to selectively treat a specific part of the prostate harboring clinically significant disease while preserving the rest of the gland. The aim of this therapeutic approach is to retain the oncological benefit of a
Externí odkaz:
https://doaj.org/article/a6b6391423794ec7bf4af46a61b1bab9